SOURCE: CLX Investment Company, Inc.

August 15, 2007 09:30 ET

CLX Investment Company Announces Acquisition of Additional Equity Interest in Zonda, Incorporated

MURRIETA, CA--(Marketwire - August 15, 2007) - CLX Investment Company, Inc. (OTCBB: CLXN) today announced that it has acquired an additional 10% of the issued and outstanding shares of Zonda, Incorporated, a developer and manufacturer of unique diagnostic tests for both the medical and non-medical markets. The additional 10% was acquired from two of Zonda's minority shareholders in exchange for restricted common stock.

Zonda's tests utilize proprietary technology that detects enzymes that are specific to the target microorganisms. The Zonda medical diagnostic tests are ideal for the clinical laboratory, point of care, and the over-the-counter (OTC) markets.

Zonda's strong intellectual property position in enzymatic detection technology will give the company a unique position in the clinical diagnostic market where there is increasing need for simple, reliable, and cost-effective rapid point of care diagnostic tests. The company's first medical test for Chlamydia is currently sold throughout Europe under the HandiLab brand and is expected to launch in the U.S. at the end of the first quarter 2008. Zonda believes it will compete successfully with all current technologies, including the "gold standard" nucleic acid amplification testing (NAAT) technology, while offering several enhanced features.

The official Zonda website (www.zondaincusa.com) is currently undergoing comprehensive updates and improvements and will be re-launched once changes have been implemented.

Zonda recently appointed Vera Leonard, who has considerable successful experience in leadership positions with major medical manufacturing and distribution companies, as its new chief executive officer.

"We are pleased that CLX has acquired an additional 10% equity interest in Zonda, bringing our total equity position to 41%, and we believe that a larger equity stake better positions CLX as a shareholder of Zonda," stated Steven R. Peacock, consultant CEO of CLX Investment Company.

"The addition of Vera Leonard as chief executive officer of Zonda only bolsters our belief that our investment will deliver long-term value for CLX shareholders. We will keep our shareholders informed as Zonda's management team institutes planned improvements of the company in all areas, including the changes to the Zonda website that have recently been initiated," added Mr. Peacock.

To sign up to receive information by email directly from CLX Investment Company when new press releases, investor newsletters, SEC filings, or other information is disclosed, please visit http://www.clxinvestments.com/email.php.

About CLX Investment Company

CLX Investment Company (www.clxinvestments.com) holds a 41% equity interest in Zonda, Inc. (www.zondaincusa.com). CLX has also invested, and holds a common stock position, in ActionView International, Inc. (www.actionviewinternational.com), a publicly traded global manufacturer and marketer of "smart" scrolling advertising billboards.

All statements included in this release, including statements regarding potential future plans and objectives of CLX Investments are forward-looking statements. Such statements are necessarily subject to risks and uncertainties, some of which are significant in scope and nature beyond CLX Investments' control. There can be no assurance that such statements will prove accurate. Actual results and future events could differ materially from those anticipated in such statements depending on many factors. Historical results are not necessarily indicative of future performance.

Contact Information

  • Contact:
    Gemini Financial Communications
    A. Beyer
    951-677-8073
    Email Contact